Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by the hepatic deficiency of porphobilinogen deaminase (PBGD) and the slowdown of heme biosynthesis. AIP symptomatology includes life-threatening, acute neurovisceral or neuropsychiatric attacks manifesting in response to pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Miriam, Paolini, Erika, Meroni, Marica, Dongiovanni, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945550/
https://www.ncbi.nlm.nih.gov/pubmed/35327450
http://dx.doi.org/10.3390/biomedicines10030648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945550/
https://www.ncbi.nlm.nih.gov/pubmed/35327450
http://dx.doi.org/10.3390/biomedicines10030648

Ejemplares similares